|
Originally published In Press as doi:10.1074/jbc.M201892200 on May 23, 2002
J. Biol. Chem., Vol. 277, Issue 32, 28987-28995, August 9, 2002
Thermodynamic Linkage between the S1 Site, the
Na+ Site, and the Ca2+ Site in the Protease
Domain of Human Activated Protein C (APC)
SODIUM ION IN THE APC CRYSTAL STRUCTURE IS COORDINATED TO FOUR
CARBONYL GROUPS FROM TWO SEPARATE LOOPS*
Amy E.
Schmidt §,
Kaillathe
Padmanabhan¶,
Matthew C.
Underwood ,
Wolfram
Bode ,
Timothy
Mather**, and
S. Paul
Bajaj 
From the Departments of Pharmacological & Physiological Sciences and Internal Medicine, Saint Louis University
Health Sciences Center, St. Louis, Missouri 63110, the
¶ Department of Biochemistry, Michigan State University, East
Lansing, Michigan 48824, Abteilung Strukturforschung,
Max-Planck-Institut fur Biochemie, D82152 Martinsried, Germany, and the
** Department of Cardiovascular Biology Research, Oklahoma
Medical Research Foundation, Oklahoma City, Oklahoma 73104
Received for publication, February 26, 2002, and in revised form, May 16, 2002
 |
ABSTRACT |
The serine protease domain of
activated protein C (APC) contains a Na+ and a
Ca2+ site. However, the number and identity of the APC
residues that coordinate to Na+ is not precisely known.
Further, the functional link between the Na+ and the
Ca2+ site is insufficiently defined, and their linkage to
the substrate S1 site has not been studied. Here, we systematically
investigate the functional significance of these two cation sites and
their thermodynamic links to the S1 site. Kinetic data reveal that
Na+ binds to the substrate-occupied APC with
Kd values of ~24 mM in the absence
and ~6 mM in the presence of Ca2+.
Sodium-occupied APC has ~100-fold increased catalytic efficiency (~4-fold decrease in Km and ~25-fold increase
in kcat) in hydrolyzing S-2288
(H-D-Ile-Pro-Arg-p-nitroanilide)
and Ca2+ further increases this
kcat slightly (~1.2-fold). Ca2+
binds to the protease domain of APC with Kd values
of ~438 µM in the absence and ~105 µM
in the presence of Na+. Ca2+ binding to the
protease domain of APC does not affect Km but
increases the kcat ~10-fold, and
Na+ further increases this kcat
~3-fold and decreases the Km value ~3.7-fold.
In agreement with the Km data, sodium-occupied APC
has ~4-fold increased affinity in binding to
p-aminobenzamidine (S1 probe). Crystallographically, the
Ca2+ site in APC is similar to that in trypsin, and the
Na+ site is similar to that in factor Xa but not thrombin.
Collectively, the Na+ site is thermodynamically linked to
the S1 site as well as to the protease domain Ca2+ site,
whereas the Ca2+ site is only linked to the Na+
site. The significance of these findings is that under physiologic conditions, most of the APC will exist in
Na2+-APC-Ca2+ form, which has 110-fold
increased proteolytic activity.
 |
INTRODUCTION |
Activated protein C
(APC)1 circulates in blood as
an inactive zymogen, protein C (PC), which is a disulfide-linked
two-chain vitamin K-dependent glycoprotein with a
Mr value of ~62,000 (1, 2). The N-terminal
light chain of PC contains a -carboxyglutamic acid (Gla) domain and
two epidermal growth factor domains (EGF1 and EGF2), whereas the heavy
chain contains the latent serine protease domain (3-5). Although
-thrombin alone can activate PC to APC, the rate is inappropriately
slow for a physiologically important reaction (1). The physiologic
activator for conversion of PC to APC is the thrombin-thrombomodulin
complex at the endothelial surface that may also involve the
endothelial PC receptor (6-8). During conversion of PC to APC, a short
peptide consisting of 12 residues in human (2) and 14 residues in
bovine (9) is removed from the N terminus of the heavy chain. The
resultant enzyme is a serine protease that inactivates two key
cofactors of coagulation, namely, factors Va and VIIIa (8). This
represents a major anticoagulant mechanism involved in the regulation
of hemostasis (8).
The Gla domain of the light chain of APC contains several Gla residues,
which are required for calcium binding to this domain (10). In
addition, the EGF1 domain contains a high affinity Ca2+-binding site in the native PC (or APC) molecule (8).
Further, Gla domainless PC also contains a single high affinity
Ca2+-binding site (11), and by mutagenesis experiments this
site is implicated to be located in the protease domain (12). Thus, it
appears that removal of the Gla domain may impair binding of calcium to
the EGF1 domain. The protease domain of APC also contains a
Na+-binding site, and residue
c2252 has been implicated in
determining the Na+-induced allosteric regulation of
catalytic activity of this as well as of other serine proteases
(13).
The proteolytic activity of APC, including the hydrolysis of amide and
ester substrates, is regulated by Na+ and Ca2+
(13-19). Initially, Castellino and co-workers (14-18) published a
series of elegant kinetic and biophysical studies describing the
potentiation of amidolytic and esterolytic activities of bovine APC. In
these studies, they observed a sigmoidal dependence of the reaction
velocity at a subsaturating concentration of substrate as a function of
Na+. In the absence of structural information available at
that time, these authors proposed that APC contained two sites or
classes of Na+ sites that may be allosterically linked. In
this report, we present data that support a heterotropic allosteric
linkage of the single Na+-binding site in the protease
domain to the S1 site of the substrate. Further, in a recent study, He
and Rezaie (19) attempted to establish linkage between the protease
domain Ca2+ site and the Na+ site. Here, we
present data which strongly indicate that occupancy of the S1 site in
APC increases the affinity of Na+ ~4-fold. He and Rezaie
(19) did not address this point and only measured the affinity of
Na+ at a single subsaturating concentration of substrate.
Such data led to obtaining a high
Kd app value for Na+
binding and therefore precluded determination of an accurate linkage
between the Na+ site and the Ca2+ site (19).
Moreover, although it is recognized that the c221-c225 loop in APC is
most likely involved in binding to Na+ (13, 19), the site
is not structurally defined. Here, we present crystallographic evidence
that the Na+ site in APC involves not only the c221-c225
loop but also the c183-c189 loop. Based upon our findings, we predict
that the Na+ site in factors VIIa and IXa will be similar
to that in APC but not thrombin.
 |
EXPERIMENTAL PROCEDURES |
Reagents--
H-D-Ile-Pro-Arg-p-nitroanilide
(S-2288) was obtained from Diapharma Inc. Polyethylene glycol 8000 (PEG) and p-aminobenzamidine (PABA) were purchased from
Sigma. D-Phe-Pro-Arg-chloromethylketone (FPRck) and
diisopropyl fluorophosphate were obtained from Calbiochem. Human PC was
purified as a by-product of the purification of factor VII (20, 21). A
total of ~25 mg of PC obtained from six isolations, each starting
with 8 liters of plasma, was used for these studies. It showed a single
band (~62,000 Da) on nonreduced and two bands (~41,000 and
~21,000 Da) on reduced SDS-PAGE (22). For Ca2+ binding
studies, FPRck-APC and Gla domainless FPRck-APC were prepared and
purified using Mono Q fast flow anion exchange resin as outlined by
Esmon et al. (23, 24) and Mather et al. (25). Decarboxylated FPRck-APC was obtained by thermal decarboxylation of Gla
residues as described earlier for prothrombin (26) and factor X (27).
For kinetic studies, human APC was obtained either from Enzyme Research
Laboratories Inc. or from Hematologic Technologies, Inc. Both proteins
gave comparable results. Gla domainless APC was prepared by
chymotrypsin treatment of APC as outlined by Hill and Castellino (18).
It was also purified according to their method with the exception that
we used a Mono Q fast protein liquid chromatography column
instead of the Q Sepharose column (18). Each protein sample was freed
of Na+ by dialysis and/or by a desalting column exactly as
described by Wells and Di Cera (28). Although this step resulted in
some loss of APC activity, it was necessary for preparing APC free of
Na+. The final concentration of Na+ after these
steps was <1 mM as measured by a conductivity meter as
outlined by Wells and Di Cera (28). The proteins were frozen at
80 °C in 20-µl aliquots, thawed, and used immediately. This freezing and thawing step did not result in a measurable loss of
activity. All of the final kinetic data presented in this paper were
obtained using APC obtained from Enzyme Research Laboratories or
Hematologic Technologies, Inc.
Amino Acid Sequencing and Gla Analysis--
Automated Edman
degradation of each protein component was performed using an Applied
Biosystems model 477A gas phase sequencer. Approximately 0.5 nmol of
protein was loaded on the filter cartridge. The proteins from SDS gels
were transferred to polyvinylidene difluoride membranes as described by
Rosenberg (29). The N-terminal sequence analysis of Gla domainless APC
or Gla domainless FPRck-APC revealed two sequences of approximately
equimolar amounts, one corresponding to the heavy chain
(Leu-Ile-Asp-Gly-Lys) and the other corresponding to the modified light
chain (Ser-Lys-His-Val-Asp). This indicates that Gla domainless APC
does not contain the Gla domain (N-terminal 41 residues of the light
chain) of APC. Decarboxylated APC contained <0.5 Gla/mol as compared
with APC, which contained 7.9 Gla/mol as measured by the specific
3H incorporation (30). APC concentrations were determined
from the absorbance at 280 nm using an extinction coefficient of 14.5 for 1% solution (2).
SDS-PAGE Analysis--
SDS gel electrophoresis was performed
using the Laemmli buffer system (22). The acrylamide concentration was
15%, and the gels were stained with Coomassie Brilliant Blue dye. All
of the proteins used in the present study were ~98% pure.
Measurement of S-2288 Amidolytic Activity of APC
Proteins--
The concentration of APC or Gla domainless APC used was
between 4 and 40 nM. The S-2288 concentration ranged from
10 µM to 3 mM. The buffer used was 50 mM Tris-HCl, pH 7.4, containing 0.1% PEG and various salt
combinations given in the legends to the appropriate figures. Chloride
salt of choline (Ch+), a bulky monovalent cation, was used
to keep the ionic strength constant to 0.2 M.
p-Nitroaniline (pNA) release was measured
continuously ( A405 nm/min) for up to 30 min
using a Beckman DU65 spectrophotometer equipped with a Soft-Pac
kinetics module. An extinction coefficient of 9.9 mM 1 cm 1 at 405 nM
was used in calculating the amount of pNA released (31). All
of the reactions were performed in triplicate. The Km and Vmax values were
obtained using the Enzyme Kinetics program from Erithacus Software. The
Kd app of binding of Na+ or
Ca2+ to the substrate-bound APC was calculated from the
kinetic data using the following equation.
|
(Eq. 1)
|
where V is the apparent maximum velocity under a
specified cation concentration represented by x,
V is the Vmax at saturating concentration of the cation, b is the maximum velocity at 0 concentration of the cation, and Kd app
is the Kd of the specified cation for the APC(S)
(substrate bound APC). The values for the correlation coefficient
(r), a measure of the strength of the goodness of fit, were
obtained using the program SPSS, version 10.0.
Ca2+ Binding to Decarboxlated FPRck-APC and Gla
Domainless FPRck-APC--
Calcium ion activity was determined by using
a Ca2+-specific electrode and a model 601A digital Ionlyzer
(Orion Research). Titrations of the protein at 29 µM in 4 ml of Tris/NaCl, pH 7.4 (50 mM Tris-HCl, 200 mM
NaCl), were performed by adding 1-2-µl increments of 40 mM CaCl2 at room temperature. In these
titrations, bound Ca2+ was taken as the difference between
the measured free Ca2+ concentration and the total added.
The data were fitted to the following equation using the program GraFit
from Erithacus Software.
|
(Eq. 2)
|
where Kd app is the dissociation
constant for binding of Ca2+ to the protein,
CaB is the maximum Ca2+ binding
capacity, and Caf and Cab
represent the free and bound concentrations of Ca2+, respectively.
Determination of Kd PABA of Binding of
PABA to APC--
The Kd app of binding of
PABA to APC was determined by its ability to competitively inhibit
S-2288 hydrolysis in the absence and presence of Na+
and/or Ca2+. The details are provided in the legend
to Fig. 6. The IC50 (concentration of PABA required for
50% inhibition) was determined by fitting the data to the following
IC50 four-parameter logistic equation from Halfman (32)
given below.
|
(Eq. 3)
|
where y is the rate of pNA release in the
presence of a given concentration of PABA represented by x,
a is the maximum rate of pNA release in the
absence of PABA, and s is the slope factor. Each point was
weighted equally, and the data were fitted to Equation 3 using the
nonlinear regression analysis program GraFit from Erithcus Software. To
obtain Kd PABA values for the
interaction of PABA with APC, we used the following equation as
described by Cheng and Prusoff (33) and further elaborated by Craig
(34).
|
(Eq. 4)
|
where [S] is the S-2288 concentration. The
Km values obtained under different conditions
(listed in Table II) were used to obtain the
Kd PABA value.
Further Refinement of the Gla Domainless FPRck-APC
Structure--
The x-ray intensity data and the atomic coordinates
(Protein Data Bank code 1aut) used for refinement were provided earlier by Mather et al. (25). The crystallization drop contained
500 µM total calcium concentration, which could provide
sufficient free Ca2+ for it to bind to the c70-c80 loop in
the protease domain. Examination of the (2Fobs Fcal) and (Fobs Fcal) electron density maps revealed that
Ca2+ and appropriate solvent water molecules could be added
to the structure. Similarly, based upon the Na+ site in
thrombin (35) and factor Xa (36), we added Na+ and
appropriate solvent water molecules in that region of the (2Fobs Fcal) electron
density map. The structure was refined using XPLOR (37) and iterative
use of computer graphics using the program O (38). In all, three rounds
of refinement were performed. The resultant structure has an
R factor of 17.8% compared with the starting R
factor of 18.4%. The final structure has 149 water molecules, one
calcium ion, and one sodium ion. All of the water molecules had
significant electron density when the (2Fobs Fcal) electron density maps were contoured at
the 1 level. The coordinates are being deposited with the Research
Collaboratory for Structural Bioinformatics.
 |
RESULTS |
Na+ Potentiation of S-2288 Hydrolysis by APC in the
Absence of Ca2+--
In earlier studies, Na+
has been shown to be the physiologically relevant and an effective
monovalent ion in potentiating the amidolytic activity of APC (13-15,
18). To further investigate the mechanism of Na+-mediated
potentiation of S-2288 hydrolysis, we determined
Km app and V'max
at several concentrations of NaCl. We used 200 mM NaCl as
the highest salt concentration in these experiments. When the concentration of Na+ was less than 200 mM,
Ch+ was used as a compensating ion to keep the ionic
strength constant to 0.2 M. One mM EDTA was
present in each buffer to eliminate the effect of divalent cations.
These data are presented in Fig. 1A. The values of
Km app and V'max
were calculated for each salt concentration using the Enzyme Kinetics
program from Erithacus Software. The results indicate that
Na+ affects both the Km app
and V'max of this reaction (Fig. 1A).
The Km app and
V'max values obtained at each Na+
concentration are given in Table I. When
V'max are plotted as a function of
Na+ concentration (Fig. 1B), the midpoint of the
curve should yield Kd app of
interaction of Na+ with APC saturated with S-2288 (APC(S))
in the absence of Ca2+; this value was calculated to be
23.9 ± 2 mM.

View larger version (20K):
[in this window]
[in a new window]
|
Fig. 1.
Sodium-mediated potentiation of S-2288
hydrolysis by APC in the absence of calcium. A, effect
of Na+ on the Km app and
Vmax of S-2288 hydrolysis. The monovalent ion
concentrations are: 0 mM Na+, 200 mM Ch+ (closed circles); 4 mM Na+, 196 mM Ch+
(open circles); 10 mM Na+, 190 mM Ch+ (closed squares); 20 mM Na+, 180 mM Ch+
(open squares); 50 mM Na+, 150 mM Ch+ (closed triangles); 100 mM Na+, 100 mM Ch+
(open triangles); 150 mM Na+, 50 mM Ch+ (closed diamonds); and 200 mM Na+, 0 mM Ch+
(open diamonds). The Km app
and V'max values were calculated using the
enzyme kinetic program GraFit from Erithacus Software and are given in
Table I. The concentration of APC used was from 4 to 40 nM;
for consistency, the data were normalized to a 40 nM enzyme
concentration. The pNA release was measured as outlined
under "Experimental Procedures." For these experiments, two stock
buffers were made. One buffer was 50 mM Trizma base,
0.1% PEG, 1 mM EDTA (acid form), and 200 mM
ChCl adjusted to pH 7.4 with HCl. In the second buffer, 200 mM ChCl was replaced by 200 mM NaCl, and the pH
was again adjusted to 7.4 with HCl. These two buffers were mixed in
appropriate proportions to yield the desired concentrations of
Na+ and Ch+. Thus, the monovalent ion
concentration was always 200 mM, and the buffer containing
200 mM Ch+ had no added source of
Na+. B, V'max as a
function of Na+. The data were fitted to Equation 1. The
Kd of Na+ for APC(S) was calculated to
be 24 ± 2 mM. The values of b and
V (converted to kcat) are given in
Table II.
|
|
View this table:
[in this window]
[in a new window]
|
Table I
Effects of sodium on the Km app and V'max app for
hydrolysis of S-2288 by APC
To keep the ionic strength constant, the monovalent ion concentration
was kept constant at 200 mM by compensating with
Ch+. The buffer used was Tris, pH 7.4, containing 0.1% PEG.
The results presented are the averages of three experiments ± S.E.
|
|
Ca2+ Potentiation of S-2288 Hydrolysis by APC in the
Absence of Na+--
These data are presented in Fig.
2. The kinetic data indicate that
Ca2+ does not change the
Km app but increases the kcat ~10-fold (Table
II). From the data of Fig.
2B, we calculate the Kd app
of Ca2+ in its interactions with APC(S) to be 438 ± 31 µM.

View larger version (18K):
[in this window]
[in a new window]
|
Fig. 2.
Calcium-mediated potentiation of S-2288
hydrolysis by APC in the absence of sodium. A, effect of
Ca2+ on the Km app and
Vmax of S-2288 hydrolysis. The Ca2+
concentrations are: 0 mM (closed circles), 0.1 mM (open circles), 0.5 mM
(closed squares), 1 mM (open
squares), 3 mM (closed triangles), and 5 mM (open triangles). The ionic strength was kept
constant in each reaction mixture by adding 185-200 mM
Ch+. The Km app and
V'max values were calculated using the enzyme
kinetic program GraFit from Erithacus Software. As in Fig. 1, the data
were normalized to a 40 nM APC concentration.
Ca2+ did not affect the
Km app, and its value ranged from 1723 to 1705 µM (Table II). B,
V'max as a function of Ca2+. As in
Fig. 1, the data were fitted to Equation 1. The
Kd app of Ca2+ for APC(S)
was calculated to be 438 ± 47 µM. The correlation
coefficient for each curve was >0.95.
|
|
View this table:
[in this window]
[in a new window]
|
Table II
Effects of sodium and calcium on the hydrolysis of S-2288 by APC
To keep the ionic strength constant, the concentration of Na+
was 200 mM in the absence of Ca2+ and 185 mM in the presence of 5 mM Ca2+. The
buffer used was Tris, pH 7.4, containing 0.1% PEG. The results
presented are the averages of three experiments ± S.E.
|
|
Na+ Potentiation of S-2288 Hydrolysis by APC in the
Presence of Ca2+--
These data are presented in Fig.
3. The kinetic data indicate that
Na+ decreases the Km app
~3.7-fold and increases the kcat ~2.8-fold.
Importantly, Ca2+ decreases the
Kd app of Na+ interaction
with APC(S) to 6.2 ± 1 mM as compared with ~24
mM (Fig. 1) when Ca2+ is absent. Thus,
Ca2+ site is thermodynamically linked to the
Na+ site.

View larger version (21K):
[in this window]
[in a new window]
|
Fig. 3.
Sodium-mediated potentiation of S-2288
hydrolysis by APC in the presence of calcium. A, effect
of Na+ on the Km app and
Vmax of S-2288 hydrolysis. The Na+
concentrations are: 0 mM Na+ (closed
circles), 2 mM Na+ (open
circles), 4 mM Na+ (closed
squares), 7 mM Na+ (open
squares), 10 mM Na+ (closed
triangles), 50 mM Na+ (open
triangles), 100 mM Na+ (closed
diamonds), and 185 mM Na+ (open
diamonds). Each reaction mixture contained 5 mM
Ca2+ and appropriate concentrations of Ch+ to
maintain constant ionic strength. Thus, at 0 mM
Na+, the Ch+ concentration was 185 mM. As in Fig. 1, the data were normalized to a 40 nM APC concentration. The
Km app values ranged from 466 µM (in the presence of Na+) to 1705 µM (in the absence of Na+) and are given in
Table II. B, V'max as a function of
Na+. The Kd app of
Na+ in binding to APC(S) in the presence of
Ca2+ was calculated to be 6.2 ± 1 mM. The
correlation coefficient for each curve was >0.95.
|
|
Ca2+ Potentiation of S-2288 Hydrolysis by APC in the
Presence of Na+--
These data are presented in Fig.
4. As noted previously (Fig. 2),
Ca2+ does not change the
Km app but increases the kcat slightly (1.2 ± 0.1-fold) in the
presence of Na+. Because the change in
V'max is very small, these data could not be
used to obtain the Kd app of
Ca2+ interaction with APC(S). However, we later show that
in the presence of Na+ this
Kd app is ~105 µM as
compared with ~438 µM (Fig. 2) when Na+ is
absent. Thus, as noted above, the Na+ site is linked to the
Ca2+ site.

View larger version (21K):
[in this window]
[in a new window]
|
Fig. 4.
Calcium-mediated potentiation of
S-2288 hydrolysis by APC in the presence of sodium. The
Ca2+ concentrations are: 0 mM (closed
circles), 0.5 mM (open circles), 1 mM (closed squares), 3 mM
(open squares), and 5 mM (closed
triangles). The concentration of Na+ in each case was
185 mM, and the Ch+ concentration was varied to
keep the ionic strength constant. As in Fig. 1, the data were
normalized to a 40 nM APC concentration. The
Km app values did not change and ranged
from 415 ± 46 to 466 ± 53 µM. The correlation
coefficient for each curve was >0.95.
|
|
The above experiments were repeated using Gla domainless APC.
Potentiation of S-2288 hydrolytic activity at several subsaturating concentrations of Na+ (± 5 mM
Ca2+) or Ca2+ (± 200 mM
Na+) was indistinguishable from that obtained with APC.
These data are consistent with extensive studies conducted by Hill and
Castellino (17) using bovine APC and Gla domainless APC. Thus, the
effects of Na+ and/or Ca2+ in potentiating the
activity of both human and bovine APC and Gla domainless APC are
comparable. Importantly, our results for the first time reveal that the
substrate binding is allosterically linked to the binding of
Na+.
Binding of Ca2+ to Human Decarboxylated FPRck-APC and
Gla Domainless FPRck-APC--
Bovine Gla domainless APC has been
reported to contain one high affinity Ca2+ site in the
presence of Na+ (11). By mutagenesis experiments, a
Ca2+-binding site in the protease domain of human APC has
also been implicated (12). Here, we have performed direct
Ca2+ binding studies with human decarboxylated FPRck-APC
and Gla domainless FPRck-APC. These data are presented in Fig.
5 and reveal that the Gla domainless
FPRck-APC contains a single Ca2+-binding site with a
Kd app value of 105 ± 11 µM, whereas the decarboxylated FPRck-APC contains two
Ca2+-binding sites with
Kd app values of 120 ± 19 µM. Because Gla domainless FPRck-APC has only one high
affinity Ca2+-binding site compared with the two in the
decarboxylated FPRck-APC, it is likely that the EGF1 domain residues
42-49 containing Asp-46 and Gln-49 that are implicated in binding to
Ca2+ (39) are flexibly disordered in the Gla domainless
FPRck-APC and cannot participate in forming the high affinity site in
this domain. Thus, the Ca2+ effects observed on the S-2288
amidolytic activity of APC are due to the Ca2+-binding site
in the protease domain and not in the EGF1 domain.

View larger version (17K):
[in this window]
[in a new window]
|
Fig. 5.
Interaction of Ca2+ with human
decarboxylated FPRck-APC and Gla domainless FPRck-APC as determined by
a Ca2+-specific electrode. The free Ca2+
concentration (Caf) is plotted against the bound
Ca2+ concentration (Cab). The
concentration of each protein was 29 µM. The binding
analysis was carried out by a nonlinear least squares fitting of the
data to Equation 2, yielding a plateau value of 55 µM
CaB for decarboxylated FPRck-APC and 28 µM CaB for Gla domainless FPRck-APC.
Note that the active site in APC is blocked and that the
Ca2+-binding data reflect interaction with APC(S).
Open circles, decarboxylated FPRck-APC; closed
circles, Gla domainless FPRck-APC.
|
|
The data presented thus far establish the interdependence of the
binding of Na+ and Ca2+ in the protease domain
of APC. APC(S) can be converted to the state with both ions bound
(sodium-APC(S)-calcium) by acquiring either Na+ (via
APC(S)-calcium) or Ca2+ (via sodium-APC(S)). The ratio of
the apparent Kd Na in the presence and
absence of Ca2+ is 3.9 and that of apparent
Kd Ca in the presence and absence of
Na+ is 4.2. Therefore, within experimental error, the net
sum of binding energy over the cycle appears to be 0. This establishes an accurate thermodynamic linkage between the Na+ site and
the protease domain Ca2+ site of APC as opposed to the
16-20-fold ratio proposed by He and Rezaie (19). Furthermore, because
Na+ affects the Km app of
S-2288 hydrolysis, there appears to be a link between the
substrate-binding and the Na+-binding site. Both in the
absence and presence of Ca2+, Na+ decreases the
Km app of S-2288 by ~3.8-fold. Using
Km app as an approximation of substrate affinity, one can complete this part of the linkage using the thermodynamic principles (40). Therefore, apparent
Kd Na and apparent
Kd Ca to the free form of APC in the
absence of substrate or the other cation can be calculated; these
values are ~95.1 mM and ~443 µM, respectively.
Effects of Na+ and Ca2+ on the Interaction
of PABA with APC--
We next investigated whether Na+
and/or Ca2+ affect the S1 part of the active site in APC.
We used the S1 site probe PABA for these studies. The interaction of
PABA with APC was determined under each of the four salt conditions.
These data are presented in Fig. 6 and
summarized in Table III. Under a
saturating concentration of Na+, the affinity of PABA for
APC was increased ~4.2-4.4-fold as compared with that in its
absence. Further, Ca2+ had essentially no effect on the
apparent Kd PABA in the absence or
presence of Na+. These
Kd PABA data agree well with the
Km data presented in the previous sections where
Na+ decreased the Km ~4-fold and
Ca2+ had no effect. Our PABA data are similar to the PABA
binding to bovine APC, where the
Kd PABA is 13 µM in the
presence and 95 µM in the absence of Na+
(17). However, the absolute apparent
Kd PABA value for human APC is ~79
µM in the presence and ~333 µM in the absence of Na+ (Table III). Thus, it would appear that
compared with human APC, bovine APC binds PABA with ~6- and
~3.5-fold higher affinity in the presence and absence of
Na+, respectively. Importantly, our data establish that
Na+ binding is linked to the substrate binding through its
S1 site.

View larger version (21K):
[in this window]
[in a new window]
|
Fig. 6.
Ability of PABA to inhibit S-2288 hydrolysis
by APC under various conditions. The six different experimental
conditions are: 1) 0 mM Na+, 0 mM
Ca2+ (closed circles); 2) 0 mM
Na+, 5 mM Ca2+ (open
circles); 3) 185 mM Na+, 0 mM
Ca2+ (closed triangles); 4) 185 mM
Na+, 5 mM Ca2+ (open
triangles); 5) 485 mM Na+, 0 mM Ca2+ (closed squares); and 6) 485 mM Na+, 5 mM Ca2+
(open squares). To keep ionic strength constant, condition 1 contained 200 mM Ch+, condition 2 contained 185 mM Ch+, condition 3 contained 15 mM
Ch+, and condition 4 contained 0 mM
Ch+. To maintain constant ionic strength (500 mM monovalent ion concentration) between conditions 5 and
6, condition 5 contained 15 mM Ch+ and
condition 6 contained 0 mM Ch+. The APC
concentration used for conditions 1 and 2 was 40 nM, and
the S-2288 concentration was 500 µM. The APC
concentration used for conditions 3-6 was 4 nM, and the
S-2288 concentration was 100 µM. The substrate S-2288 was
mixed with varying concentrations of PABA before addition of APC to the
reaction mixture. S-2288 hydrolysis was monitored by pNA
release. The IC50 values were calculated using Equation 3.
The apparent Kd PABA values were
obtained using Equation 4 and are listed in Table III.
|
|
View this table:
[in this window]
[in a new window]
|
Table III
Effects of calcium and sodium on the dissociation constants for
interaction of PABA with APC
To keep the ionic strength constant, the concentration of Na+
was 200 mM in the absence and 185 mM in the
presence of 5 mM Ca2+. The results presented are
the averages of two experiments ± S.E.
|
|
Location of the Protease Domain Ca2+ Site and the
Na+ Site in the Gla Domainless FPRck-APC Crystal
Structure--
To provide a structural basis for the linkage between
cation-binding sites and the S1 site, we refined the APC structure
after including Ca2+ and Na+ in the protease
domain. A schematic representation of the protease domain of human APC
depicting the Ca2+ site and the Na+ site are
presented in Fig. 7A. Details
of the Ca2+- and the Na+-binding sites are
presented in Fig. 7 (B and C, respectively). The
Ca2+-binding site is similar to that in trypsin (41) and
involves the carboxylates of Glu-c70 and Glu-c80, carbonyl oxygens of
c72 and c75, and two water molecules. The Na+-binding site
is similar to that in factor Xa (36) and involves carbonyl oxygens of
c184A, c185, c221A, and c2243
and two water molecules.

View larger version (43K):
[in this window]
[in a new window]
|
Fig. 7.
Location of the Na+ site as well
as the Ca2+ site in the protease domain of APC.
A, overall fold of the protease domain. -Sheets are in
red, -helices are in blue, the
Ca2+-binding loop is in white, the two
Na+-binding loops are in yellow and
white, and the autolysis loop is in magenta. The
active site residues (Asp-c102, His-c57, and Ser-c195) are labeled
D, H, and S, respectively. The N and C
termini are marked N and C, respectively. The
positions of residues that are important in binding to Na+
as well as to Ca2+ are labeled. The residue numbers are
based upon chymotrypsin numbering as outlined by Mather et
al. (25). B, details of the Ca2+-binding
site in the protease domain. The main chain carbonyl groups of c72 and
c75 and the carboxyl side chains of residues c70 and c80 along with two
water molecules that coordinate to Ca2+ are depicted. The
Ca2+-binding loop is colored by atom type.
Ca2+ is shown as a white sphere, and water
molecules are shown as red spheres. The dotted
lines represent coordination of Ca2+ with its ligands.
w, oxygen of water. C, details of the
Na+-binding site and its relationship to the S1 site. The
two Na+-binding loops, c183-c189 (colored red)
and c221-c225 (colored magenta), are shown. The
Na+ is coordinated by the carbonyl oxygen atoms of c184A,
c185, c221A, c224, and two water molecules. Tyr-c225 residue, an
important determinant for Na+ binding (13), and the S1
specificity binding pocket residue, Asp-c189, that is linked to the
Na+ site as well as to the Tyr-c228, are also depicted.
Na+ is shown as a blue sphere, and water
molecules are shown as red spheres. The dotted
lines represent hydrogen bonds as well as coordination of
Na+ with its ligands. w, oxygen of water.
|
|
 |
DISCUSSION |
The purpose of the present study was to structurally define the
protease domain Ca2+ site as well as the Na+
site and their roles in regulating the catalytic activity of human APC.
The spatial relationship of the Ca2+ site, the
Na+ site, the autolysis loop, the Asp-c189 S1 site, and the
catalytic triad is provided in Fig. 7A. Dang and Di Cera
(13) recently reported that several serine proteases, including those
in coagulation, possess a functional Na+ site. X-ray
crystal structures of thrombin (35, 42) and factor Xa (35, 36) are
reported where the Na+ site in these molecules is defined.
The Na+ site in thrombin uses a single loop involving the
carbonyl oxygen atoms of residues c221A and c224 as well as four water
molecules, whereas the Na+ site in factor Xa uses two loops
involving the carbonyl oxygen atoms of residues c185, c185A, c222, and
c224 as well as two water molecules. The nature of the residue c225
plays an important role in orienting the carbonyl oxygen atom of c224
toward the Na+ coordination shell (35, 36, 42). As shown in
Fig. 7C, the Na+ site in APC resembles that of
factor Xa but not thrombin. This may be due to the insertion of three
residues in the c183 loop of thrombin. As a result of this insertion,
the carbonyl oxygens of this loop in thrombin are spatially distant and
unable to coordinate with Na+. Instead, the cavity in
thrombin is filled with water molecules, two of which are optimally
situated to coordinate with Na+.
In the presence or absence of Ca2+, Na+
increased the affinity of S-2288 to APC (Table II) by ~4-fold and
binding of PABA (Table III) by a similar fold. Because Ca2+
does not influence the Km app value of
S-2288 and has essentially no effect on the PABA binding, it would
appear that these effects are primarily mediated through the S1 site in
APC. These results can be readily rationalized, because the Na+ site in APC is directly linked to the S1 specificity
pocket residue Asp-c189 (Fig. 7C). Occupancy of the
Na+ site could rigidify the c189 side chain as well as the
c183-c189 loop for optimal interaction with the basic P1 residue (Arg)
of the substrate or the basic amino groups of the S1 probe, PABA.
In the absence of Na+, Ca2+ increased the
kcat of S-2288 hydrolysis ~10-fold (Table II).
In the presence of Na+, however, Ca2+ had a
minimal effect (~1.2-fold) on the hydrolysis of S-2288. Of interest,
Ca2+ in the presence or absence of Na+ had no
effect on the Km app of S-2288
hydrolysis as well as on the PABA binding. Thus, Ca2+ does
not affect the ground state binding of substrates/inhibitors to APC.
The ~10-fold increase in kcat for S-2288
hydrolysis thus appears to be due to a decrease in the transition state
energy. All of the catalytic effects of Ca2+ on APC are
remarkably similar to those observed earlier for factor Xa (43). This
is not surprising because both proteases are structurally similar.
Of interest is the fact that the Na+ site and the protease
domain Ca2+ site are thermodynamically linked. Thus,
Ca2+ increases the affinity of Na+ by
~4.0-fold, and Na+ increases the affinity of protease
domain Ca2+ binding by a similar fold. The thermodynamic
linkage between the Na+ site and the protease domain
Ca2+ site of APC is depicted in Fig.
8. This part of the linkage is supported
by the data presented in Figs. 1, 2, 3, and 5. Thus, although the
effects of Na+ and Ca2+ at individual steps of
the thermodynamic cycle depicted in Fig. 8 are different, the
overall change in apparent affinity for Na+ or
Ca2+ is the same regardless of the pathway followed in
going from APC(S) to the sodium-APC(S)-calcium state or the pathway
followed in going from APC to the sodium-APC-calcium state.

View larger version (23K):
[in this window]
[in a new window]
|
Fig. 8.
Linkage relations in binding of S-2288,
Na+, and Ca2+ to the protease domain of
APC. In addition to the substrate-binding site, the protease
domain of APC possesses a monovalent (Na+) as well as a
divalent (Ca2+) cation-binding site. Thus, the protease
domain can exist in eight forms: APC, APC(S), sodium-APC, APC-calcium,
sodium-APC(S), APC(S)-calcium, sodium-APC-calcium, and
sodium-APC(S)-calcium. The dissociation constant listed for each
equilibrium was calculated using the data of Figs. 1, 2, 3, and 5.
S, substrate. Note that the apparent
Kd Na and apparent
Kd Ca depicted on the left
of the figure are not experimentally determined values but rather are
calculated values based upon thermodynamic principles (40).
|
|
A major observation of significance in this paper is that the S1 site
in APC is linked to the Na+ site. Hence, occupancy of the
S1 site increases the affinity of Na+ ~4-fold, and
Na+ increases the affinity (Km) of the
substrate by a similar fold. This part of the thermodynamic linkage
between the S1 site and the Na+ site in APC is also
depicted in Fig. 8 and is supported by the data presented in Figs. 1,
3, and 6. Consequently, although the effects of Na+ and
substrate at individual steps of this part of the thermodynamic cycle
are different, the overall change in apparent affinity for Na+ or substrate S-2288 is the same regardless of the
pathway followed in going from APC to the sodium-APC(S) state or the
pathway followed in going from APC-calcium to the sodium-APC(S)-calcium
state. Note that Ca2+ is not thermodynamically linked to
the S1 site. Thus, in going from APC to the APC(S)-calcium state, the
affinity of Ca2+ or the substrate for APC is not altered
regardless of the pathway followed in Fig. 8. Similarly, in going from
sodium-APC to the sodium-APC(S)-calcium state, the affinity of
Ca2+ or the substrate for sodium-APC is not altered
regardless of the pathway followed in Fig. 8.
The plasma concentration of Ca2+ is ~1 mM and
that of Na+ is ~150 mM. Under these
conditions, ~85% of the formed APC will exist in the
sodium-APC-calcium state. Binding of the substrate further drives this
equilibrium in the direction that favors APC binding to Na+
and Ca2+. Thus, the overall effect of the linkage between
the S1 site, the Na+ site, and the Ca2+ site is
that during physiologic hemostasis, the APC formed will mostly exist in
the sodium-APC-calcium state that has maximum anticoagulant activity.
Notably, the linkage between Ca2+ and Na+ and
the S1 site are essentially the same as proposed for factor Xa earlier
(43). This similarity between the two proteases (APC and factor Xa) is
consistent with the structural resemblance in the Ca2+
site, the Na+ site, and the S1 site.
The Ca2+ site in the APC protease domain (Fig.
7B) is typical of that found in trypsin-like proteases (41).
It is of note that the c70-c80 calcium loop in APC contains three
basic and two hydrophobic Trp residues (25). The serine proteases that bind Ca2+ contain primarily acidic and polar residues in
this loop, which facilitate attraction of a positively charged divalent
cation. Thus, trypsin contains four acidic and three polar residues
(41), and elastase contains two acidic and seven polar residues (44). Similarly, human factor IXa contains five acidic and five polar residues and is thought to bind Ca2+ in this loop (45).
Human factor VIIa contains six acidic and three polar residues and
contains a Ca2+-binding site in this loop (46).
Furthermore, the Gla domainless PC or APC was reported to contain only
a single Ca2+-binding site (11), which was thought to be
located in the EGF1 domain (39). Based upon the above considerations,
Bajaj et al. (45) had initially proposed that PC or APC
might not contain a Ca2+-binding site in the protease
domain. However, recent mutagenesis experiments (12), direct binding
studies (Fig. 5), and crystal structure data (Fig. 7B)
clearly reveal the presence of a Ca2+-binding site in the
c70-c80 loop of APC. Thus, the Ca2+ site in the Gla
domainless PC or APC previously attributed to the EGF1 domain is most
likely the Ca2+ site in the protease domain.
Structural features of the c70-c80 Ca2+-binding loop of
APC are shown in Fig. 9. A unique feature
of this loop appears to be that all three basic residues and the two
hydrophobic Trp residues are exposed to the solvent. The other
hydrophobic residue Leu-c73 is buried in a hydrophobic pocket involving
spatially close neighbors. The Trp-c76 is stabilized by two hydrogen
bonds and van der Waals' interactions involving the side chain carbon
atoms of Lys-c78. Similarly, Trp-c79 is held in place by a hydrogen
bond involving the carbonyl oxygen of Gly-c69. The hydroxyl group of
Tyr-c71 in this loop is hydrogen-bonded to a water molecule as well as to the side chain of Thr-c22. Further, the phenyl ring of Tyr-c71 is
stabilized through van der Waals' interactions with the side chain
carbon atoms of Arg-c24. Thus, it is not unreasonable to conclude that
the binding of Ca2+ to this loop provides favorable energy
for the two Trp residues to stay exposed to the solvent. Interestingly,
these two Trp resides have been implicated to be important for the
activation of PC by the thrombin-thrombomodulin complex (8).

View larger version (36K):
[in this window]
[in a new window]
|
Fig. 9.
Surface features of the APC protease domain
Ca2+-binding loop. Location of Leu-c73 in a
hydrophobic pocket comprised of Val-c32, Leu-c40, and Trp-c141 is shown
in white. Two hydrophobic residues and three basic residues,
namely, Trp-c76, Trp-c79, Arg-c74, Arg-c75, and Lys-c78 are exposed to
the solvent. These residues are stabilized by hydrogen bonds and van
der Waals' interactions and are discussed in the text. The
dotted lines represent hydrogen bonds as well as
coordination of Ca2+ with its ligands. Magenta
sphere (Ca), calcium; red sphere
(w), oxygen of water.
|
|
 |
CONCLUDING REMARKS |
In this report, we provide evidence that the Na+ site
in APC is thermodynamically linked to the S1 site as well as to the
protease domain Ca2+ site. Such information was critical in
defining the accurate thermodynamic cycle for the linkage of the
Na+ site to the Ca2+ site as well as to the S1
site (Fig. 8). Our data also indicate that most of the APC under
physiologic conditions will exist as sodium-APC-calcium, which has
maximal biologic activity. These conclusions with respect to function
are supported by the structural data. The Ca2+ site in APC
is similar to other trypsin-like proteases (41), and the
Na+ site is similar to factor Xa (36) but not thrombin
(35). Based upon the sequence comparison (47) and structural homology between factor Xa (36), factor IXa (48), and factor VIIa (46), we
postulate that factors IXa and VIIa will have Na+ sites
similar to that of factor Xa and APC. If so, then Na+
appears to play a structural role in maintaining the fully active conformer of the protease domain in these vitamin
K-dependent proteins.
 |
ACKNOWLEDGEMENTS |
We thank Dr. Tomasz Heyduk for useful
discussions and Dana Oliver for help with the statistical analyses.
 |
Addendum |
Fig. 2 originally present in Papers in Press has
been deleted. In this figure the velocity curve as a function of
substrate concentration showed weak sigmoidal behavior at subsaturating concentration (1 mM) of Na+. Subsequently, when
several simulation experiments were conducted each at different
subsaturating concentrations of Na+, linear curves were
observed. Moreover, at each substrate concentration, the ratio of
enzyme-substrate complex to the enzyme-Na+-substrate
complex was also unchanged. Thus, Fig. 2 was removed, and the text has
been adjusted appropriately.
 |
FOOTNOTES |
*
This work was supported by National Institutes of Health
Grants HL36365 and HL70369.The costs of publication of this
article were defrayed in part by the
payment of page charges. The article must therefore be hereby marked
"advertisement" in
accordance with 18 U.S.C. Section
1734 solely to indicate this fact.
The atomic coordinates and the structure factors (code 1aut) have been deposited in the Protein Data Bank, Research Collaboratory for Structural Bioinformatics, Rutgers University, New Brunswick, NJ (http://www.rcsb.org/).
§
Supported in part by Predoctoral Fellowship 0110191Z from the
American Heart Association Heartland Affiliate.

To whom correspondence should be addressed: Div. of Hematology
and Oncology, St. Louis University Health Sciences Center, 3635 Vista
Ave., P.O. Box 15250, St. Louis, MO 63110-0250. Tel.: 314-577-8499; Fax: 314-773-1167; E-mail: Bajajps@slu.edu.
Published, JBC Papers in Press, May 23, 2002, DOI 10.1074/jbc.M201892200
2
For comparison, the chymotrypsin amino acid
numbering system is used. Thus, the numbers with the prefix "c"
(e.g. c225) refer to the chymotrypsin equivalents for the
protease domain of APC. Where insertions occur, the chymotrypsin
numbering is followed by a capital letter, such as A.
3
In APC (25), the residues in the c183 loop are
numbered as c184, c184A, c185, c186, c186A, and
c187. In factor Xa (36), the equivalent residues in this loop are
numbered as c184, c185, c185A, c185B, c186, and
c187. The residues in the c221 loop of APC are numbered as c221,
c221A, c222, c223, c224, and c225. The equivalent
residues in this loop of factor Xa are numbered as c221,
c222, c222A, c223, c224, and c225. The residues
involved in binding to Na+ in APC and factor Xa are given
in italics in this footnote.
 |
ABBREVIATIONS |
The abbreviations used are:
APC, activated
protein C;
PC, protein C;
S-2288, H-D-Ile-Pro-Arg-p-nitroanilide;
PEG, polyethylene glycol 8000;
Gla, -carboxyglutamic acid;
Ch+, choline;
FPRck, D-Phe-Pro-Arg-chloromethylketone;
PABA, p-aminobenzamidine;
pNA, p-nitroaniline;
EGF, epidermal growth factor;
APC(S), APC
saturated with S-2288.
 |
REFERENCES |
| 1.
|
Stenflo, J.
(1976)
J. Biol. Chem.
251,
355-363[Abstract/Free Full Text]
|
| 2.
|
Kisiel, W.
(1979)
J. Clin. Invest.
64,
761-769[Medline]
[Order article via Infotrieve]
|
| 3.
|
Long, G. L.,
Belagaje, R. M.,
and MacGillivray, T. A.
(1984)
Proc. Natl. Acad. Sci. U. S. A.
81,
5653-5656[Abstract/Free Full Text]
|
| 4.
|
Foster, D.,
and Davie, E. W.
(1984)
Proc. Natl. Acad. Sci. U. S. A.
81,
4766-4770[Abstract/Free Full Text]
|
| 5.
|
Beckmann, R. J.,
Schmidt, R. J.,
Santerre, R. F.,
Plutzky, J.,
Crabtree, G. R.,
and Long, G. L.
(1985)
Nucleic Acids Res.
13,
5233-5247[Abstract/Free Full Text]
|
| 6.
|
Esmon, C. T.,
and Owen, W. G.
(1981)
Proc. Natl. Acad. Sci. U. S. A.
78,
2249-2252[Abstract/Free Full Text]
|
| 7.
|
Owen, W. G.,
and Esmon, C. T.
(1981)
J. Biol. Chem.
256,
5532-5535[Abstract/Free Full Text]
|
| 8.
|
Esmon, C. T.
(2001)
in
Hemostasis and Thrombosis: Basic Principles & Clinical Practice
(Colman, R. W.
, Hirsh, J.
, Marder, V. J.
, Clowes, A. W.
, and George, J. N., eds), 4th Ed.
, pp. 335-353, Lippincott, Williams & Wilkins, Philadelphia, PA
|
| 9.
|
Kisiel, W.,
Canfield, W. M.,
Ericsson, L. H.,
and Davie, E. W.
(1977)
Biochemistry
16,
5824-5831[CrossRef][Medline]
[Order article via Infotrieve]
|
| 10.
|
Castellino, F. G.
(1995)
Trends Cardiovasc. Med.
5,
55-62
|
| 11.
|
Johnson, A. E.,
Esmon, N. E.,
Laue, T. M.,
and Esmon, C. T.
(1983)
J. Biol. Chem.
258,
5554-5560[Free Full Text]
|
| 12.
|
Rezaie, A.,
Mather, T.,
Sussman, F.,
and Esmon, C. T.
(1994)
J. Biol. Chem.
269,
3151-3154[Abstract/Free Full Text]
|
| 13.
|
Dang, Q. D.,
and Di Cera, E.
(1996)
Proc. Natl. Acad. Sci. U. S. A.
93,
10653-10656[Abstract/Free Full Text]
|
| 14.
|
Steiner, S. A.,
and Castellino, F. J.
(1982)
Biochemistry
21,
4609-4614[CrossRef][Medline]
[Order article via Infotrieve]
|
| 15.
|
Steiner, S. A.,
and Castellino, F. J.
(1985)
Biochemistry
24,
609-617[CrossRef][Medline]
[Order article via Infotrieve]
|
| 16.
|
Steiner, S. A.,
and Castellino, F. J.
(1985)
Biochemistry
24,
1136-1141[CrossRef][Medline]
[Order article via Infotrieve]
|
| 17.
|
Hill, K. A. W.,
and Castellino, F. J.
(1986)
J. Biol. Chem.
261,
14991-14996[Abstract/Free Full Text]
|
| 18.
|
Hill, K. A. W.,
and Castellino, F. J.
(1987)
J. Biol. Chem.
262,
140-146[Abstract/Free Full Text]
|
| 19.
|
He, X.,
and Rezaie, A. R.
(1999)
J. Biol. Chem.
274,
4970-4976[Abstract/Free Full Text]
|
| 20.
|
Bajaj, S. P.,
Rapaport, S. I.,
and Brown, S. F.
(1981)
J. Biol. Chem.
256,
253-259[Abstract/Free Full Text]
|
| 21.
|
Bajaj, S. P.,
Rapaport, S. I.,
Maki, S. L.,
and Brown, S. F.
(1983)
Prep. Biochem.
13,
191-214[Medline]
[Order article via Infotrieve]
|
| 22.
|
Laemmli, U. K.
(1970)
Nature
227,
680-685[CrossRef][Medline]
[Order article via Infotrieve]
|
| 23.
|
Esmon, C. T.,
Esmon, N. L., Le,
Bonniec, B. F.,
and Johnson, A. E.
(1993)
Methods Enzymol.
222,
359-385[Medline]
[Order article via Infotrieve]
|
| 24.
|
Esmon, N. L.,
DeBault, L. E.,
and Esmon, C. T.
(1983)
J. Biol. Chem.
258,
5548-5553[Free Full Text]
|
| 25.
|
Mather, T.,
Oganessyan, V.,
Hof, P.,
Huber, R.,
Foundling, S.,
Esmon, C.,
and Bode, W.
(1996)
EMBO J.
15,
6822-6831[Medline]
[Order article via Infotrieve]
|
| 26.
|
Bajaj, S. P.,
Price, P. A.,
and Russell, W. A.
(1982)
J. Biol. Chem.
257,
3726-3731[Free Full Text]
|
| 27.
|
Sabharwal, A. K.,
Padmanabhan, K.,
Tulinsky, A.,
Mathur, A.,
Gorka, J.,
and Bajaj, S. P.
(1997)
J. Biol. Chem.
272,
22037-22045[Abstract/Free Full Text]
|
| 28.
|
Wells, C. M.,
and Di Cera, E.
(1992)
Biochemistry.
31,
11721-11730[CrossRef][Medline]
[Order article via Infotrieve]
|
| 29.
|
Rosenberg, I. M.
(1996)
Protein Analysis and Purification: Benchtop Techniques
, pp. 153-156, Birkhäuser, Boston, MA
|
| 30.
|
Price, P. A.,
Williamson, M. K.,
and Epstein, D. J.
(1981)
J. Biol. Chem.
256,
1172-1176[Free Full Text]
|
| 31.
|
Lottenberg, R.,
and Jackson, C. M.
(1983)
Biochim. Biophys. Acta
742,
558-564[CrossRef][Medline]
[Order article via Infotrieve]
|
| 32.
|
Halfman, C. J.
(1981)
Methods Enzymol.
74,
481-508[Medline]
[Order article via Infotrieve]
|
| 33.
|
Cheng, Y.-C.,
and Prusoff, W. H.
(1973)
Biochem. Pharmacol.
22,
3099-3108[CrossRef][Medline]
[Order article via Infotrieve]
|
| 34.
|
Craig, D. A.
(1993)
Trends Pharmacol. Sci.
14,
89-91[CrossRef][Medline]
[Order article via Infotrieve]
|
| 35.
|
Zhang, E.,
and Tulinsky, A.
(1997)
Biophys. Chem.
63,
185-200[CrossRef][Medline]
[Order article via Infotrieve]
|
| 36.
|
Padmanabhan, K.,
Padmanabhan, K. P.,
Tulinsky, A.,
Park, C. H.,
Bode, W.,
Huber, R.,
Blankenship, D. T.,
Cardin, A. D.,
and Kisiel, W.
(1993)
J. Mol. Biol.
232,
947-966[CrossRef][Medline]
[Order article via Infotrieve]
|
| 37.
|
Bruenger, A. T.
(1992)
XPLOR, version 3.1
, Yale University Press, New Haven, CT
|
| 38.
|
Jones, T. A.,
Zou, J. Y.,
Cowan, S. W.,
and Kjeldgaard, M.
(1991)
Acta Crystallogr. Sect. A
47,
110-119[CrossRef]
|
| 39.
|
Stenflo, J.
(1991)
Blood
78,
1637-1651[Free Full Text]
|
| 40.
|
Fersht, A.
(1998)
Structure and Mechanism in Protein Science
, pp. 125-126, Freeman and Company, New York
|
| 41.
|
Bode, W.,
and Schwager, P.
(1975)
J. Mol. Biol.
98,
693-717[CrossRef][Medline]
[Order article via Infotrieve]
|
| 42.
|
Guinto, E. R.,
Caccia, S.,
Rose, T.,
Fütterer, K.,
Waksman, G.,
and Di Cera, E.
(1999)
Proc. Natl. Acad. Sci. U. S. A.
96,
1852-1857[Abstract/Free Full Text]
|
| 43.
|
Underwood, M. C.,
Zhong, D.,
Mathur, A.,
Heyduk, T.,
and Bajaj, S. P.
(2000)
J. Biol. Chem.
275,
36876-36884[Abstract/Free Full Text]
|
| 44.
|
Meyer, E.,
Cole, G.,
Radhakrishnan, R.,
and Epp, O.
(1988)
Acta Crystallogr. Sect. B Struct. Sci.
44,
26-39[CrossRef]
|
| 45.
|
Bajaj, S. P.,
Sabharwal, A. K.,
Gorka, J.,
and Birktoft, J. J.
(1992)
Proc. Natl. Acad. Sci. U. S. A.
89,
152-156[Abstract/Free Full Text]
|
| 46.
|
Banner, D. W.,
D'Arcy, A.,
Chene, C.,
Winkler, F. K.,
Guha, A.,
Koningberg, W. H.,
Nemerson, Y.,
and Kirchhofer, D.
(1996)
Nature
380,
41-46[CrossRef][Medline]
[Order article via Infotrieve]
|
| 47.
|
Bajaj, S. P.,
and Birktoft, J. J.
(1993)
Methods Enzymol.
222,
96-128[CrossRef][Medline]
[Order article via Infotrieve]
|
| 48.
|
Brandstetter, H.,
Bauer, M.,
Huber, R.,
Lollar, P.,
and Bode, W.
(1995)
Proc. Natl. Acad. Sci. U. S. A.
92,
9796-9800[Abstract/Free Full Text]
|
Copyright © 2002 by The American Society for Biochemistry and Molecular Biology, Inc.

CiteULike Complore Connotea Del.icio.us Digg Reddit Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
F. Marino, Z.-W. Chen, C. E. Ergenekan, L. A. Bush-Pelc, F. S. Mathews, and E. Di Cera
Structural Basis of Na+ Activation Mimicry in Murine Thrombin
J. Biol. Chem.,
June 1, 2007;
282(22):
16355 - 16361.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. J. Page and E. Di Cera
Role of na+ and k+ in enzyme function.
Physiol Rev,
October 1, 2006;
86(4):
1049 - 1092.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. P. Bajaj, A. E. Schmidt, S. Agah, M. S. Bajaj, and K. Padmanabhan
High Resolution Structures of p-Aminobenzamidine- and Benzamidine-VIIa/Soluble Tissue Factor: UNPREDICTED CONFORMATION OF THE 192-193 PEPTIDE BOND AND MAPPING OF Ca2+, Mg2+, Na+, AND Zn2+ SITES IN FACTOR VIIa
J. Biol. Chem.,
August 25, 2006;
281(34):
24873 - 24888.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
L. A. Bush, R. W. Nelson, and E. Di Cera
Murine Thrombin Lacks Na+ Activation but Retains High Catalytic Activity
J. Biol. Chem.,
March 17, 2006;
281(11):
7183 - 7188.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
K. E. Mengwasser, L. A. Bush, P. Shih, A. M. Cantwell, and E. Di Cera
Hirudin Binding Reveals Key Determinants of Thrombin Allostery
J. Biol. Chem.,
July 22, 2005;
280(29):
26997 - 27003.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. O. Pineda, C. J. Carrell, L. A. Bush, S. Prasad, S. Caccia, Z.-W. Chen, F. S. Mathews, and E. Di Cera
Molecular Dissection of Na+ Binding to Thrombin
J. Biol. Chem.,
July 23, 2004;
279(30):
31842 - 31853.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. Prasad, K. J. Wright, D. Banerjee Roy, L. A. Bush, A. M. Cantwell, and E. Di Cera
Redesigning the monovalent cation specificity of an enzyme
PNAS,
November 25, 2003;
100(24):
13785 - 13790.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
R. M. Camire
Prothrombinase Assembly and S1 Site Occupation Restore the Catalytic Activity of FXa Impaired by Mutation at the Sodium-binding Site
J. Biol. Chem.,
September 27, 2002;
277(40):
37863 - 37870.
[Abstract]
[Full Text]
[PDF]
|
 |
|
Copyright © 2002 by the American Society for Biochemistry and Molecular Biology.
|
Advertisement
Advertisement
|